Answers are grounded in this paper and cite their sources.
Prospective observation indicates AIMS65 predicts inhospital outcomes in chronic liver disease patients, suggesting a valuable risk stratification tool.
BACKGROUND: Upper gastrointestinal bleeding (UGIB) in chronic liver disease (CLD) carries a high risk and requires early stratification. This study evaluated the prognostic value of the AIMS65 score in CLD patients with UGIB. METHODS: This prospective observational study included 131 adult CLD patients with UGIB admitted over 18 months at Rajendra Institute of Medical Sciences, Ranchi. Patients were grouped as AIMS65 <3 and AIMS65 ≥3. The primary outcome was inhospital mortality; secondary outcomes were intensive care unit (ICU) admission, rebleeding, and length of hospital stay. Mortality prediction by AIMS65 was compared with Child-Pugh and model for end-stage liver disease (MELD) scores. RESULTS: The median age was 54 years (interquartile range: 46-63), and 54.9% were male. Variceal bleeding was present in 68.0% of patients. Compared with AIMS65 <3, patients with AIMS65 ≥3 had higher inhospital mortality (31.3% vs. 4.7%), ICU admission (50.7% vs. 12.5%), rebleeding (40.3% vs. 7.8%), and longer hospital stay (13.5 ± 3.8 vs. 7.3 ± 2.1 days) (all P < 0.001). AIMS65 showed the highest discrimination for inhospital mortality (area under the curve: 0.88; 95% confidence interval [CI]: 0.80-0.95), compared with Child-Pugh (0.84; 95% CI: 0.75-0.92) and MELD (0.81; 95% CI: 0.72-0.90). CONCLUSIONS: Higher AIMS65 scores were associated with adverse inhospital outcomes in CLD patients with UGIB. AIMS65 showed better mortality discrimination than Child-Pugh and MELD in this cohort and may be a useful bedside risk stratification tool.
No takes yet. Share an insight, caveat, or question.
Bharti et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: